Aquavit Wins a Trademark Case over AQUAGOLD in European Union Intellectual Property Office Against a Counterfeiter
Retrieved on:
Thursday, April 15, 2021
b'NEW YORK, April 15, 2021 /PRNewswire/ --The European Union Intellectual Property Office (EUIPO) declared that U-BioMed\'s falsely registered AQUAGOLD European Union trademark (No.
Key Points:
- b'NEW YORK, April 15, 2021 /PRNewswire/ --The European Union Intellectual Property Office (EUIPO) declared that U-BioMed\'s falsely registered AQUAGOLD European Union trademark (No.
- 17902149) is invalid in its entirety, as it was originally created and owned by Aquavit Pharmaceuticals, Inc. ("Aquavit").
- The division concluded that "the [Aquavit\'s] application was totally successful and U-BioMed\'s European Union trademark has been declared invalid for all the contested goods.
- "\nAquavit\'s microchannel technology, AQUAGOLD, was launched in 2014 at the American Academy of Dermatology, the largest dermatology conference in the world.